Memantine Hydrochloride Capsule, Extended Release
Product Images NDC 70771-1321

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 70771-1321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Memantine Hydrochloride Extended-release Capsules, 7 mg (D1f0893c 420d 4045 B773 B402760464c1 06)

Memantine Hydrochloride Extended-release Capsules, 7 mg (D1f0893c 420d 4045 B773 B402760464c1 06)
This is a description of a medication called "Memantine Hydrochloride" in extended-release capsules. Each capsule contains 7mg of the medication. The instructions state to see the package insert for prescribing information and typical dosages. The medication is to be stored in a controlled room temperature of 20-25°C and dispensed in a tightly closed container. The medication is manufactured by Cadia Healthcare Ltd in India. No other notable information is available.*
FDA Label Image

Memantine Hydrochloride Extended-release Capsules, 14 mg (D1f0893c 420d 4045 B773 B402760464c1 07)

Memantine Hydrochloride Extended-release Capsules, 14 mg (D1f0893c 420d 4045 B773 B402760464c1 07)
This is a label of medication, specifically Memantine Hydrochloride Extended-Release capsules. The usual dosage is not specified and must be obtained from the package insert or prescribing information. The medication should be stored at a temperature between 20-25°C and kept in a tightly closed container. It is important to keep this medication and all drugs out of the reach of children. The label also includes the manufacturer's name, Cadia Healthcare Ltd, which is located in India.*
FDA Label Image

Memantine Hydrochloride Extended-release Capsules, 21 mg (D1f0893c 420d 4045 B773 B402760464c1 08)

FDA Label Image

Memantine Hydrochloride Extended-release Capsules, 28 mg (D1f0893c 420d 4045 B773 B402760464c1 09)

Memantine Hydrochloride Extended-release Capsules, 28 mg (D1f0893c 420d 4045 B773 B402760464c1 09)
Description not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.